Skip to Content

Alere Hosts Event Responding to Challenge of Antimicrobial Resistance (AMR) in Ireland

March 08, 2017: The high-level, multi-stakeholder roundtable event explored the uptake of antimicrobial stewardship policy measures globally and identified sustainable solutions to ensure Ireland can combat the challenge of drug resistance.

Alere Hosts Event Responding to Challenge of Antimicrobial Resistance (AMR) in Ireland

The increase in AMR is compromising the ability to treat infectious diseases, as well as undermining many other advances in health and medicine. Improved infection control compliance across a range of healthcare settings and addressing the attitudes and behaviours of prescribers is essential to curb the trend of increasing treatment-resistant bacteria and prevent healthcare-associated infections.

In Ireland, the consumption of antibiotics is relatively high by European standards. Ireland has the ninth highest rate of antibiotic consumption outside of the hospital in 30 countries. Irish pig farmers give their animals up to four times as much antibiotics as Danish farmers and the transfer of resistant bacteria through the food chain is an ongoing challenge. Epidemics of diseases and infections like tuberculosis and pneumonia could hit Ireland again and become non-treatable as antibiotic resistance increases to crisis levels.

While progress has been made in addressing AMR in Ireland, much work remains to be done.

At the event, Dr. Kieran Clarke, Alere’s Global Product Director – Pneumonia and Antimicrobial Stewardship, alongside guest speakers that included Philip Howard, Consultant Antimicrobial Pharmacist, Leeds Teaching Hospitals NHS Trust and Dr. Akke Vellinga, Epidemiologist, NUI Galway, put forward steps to aid the government and the HSE in the fight against antibiotic resistance.  The Government has committed to publish a National Action Plan on antimicrobial resistance in May 2017, in line with commitments made by the Government to the World Health Organization (WHO).

The companies, websites, products and services, and brands referenced and linked to/from this website are not sponsored or endorsed by, or otherwise affiliated with, Alere or TestTargetTreat.com. The third-party products and services referenced and linked to/ from this website are included for informational purposes only, and have not been tested or approved by Alere or TestTargetTreat.com. Neither Alere nor TestTargetTreat.com makes any representations or warranties regarding third-party products or services, and shall not be liable for any claims arising from those products or services or your use thereof.

Explore Related Content and Videos

Case Study: Tuberculosis

Which pathway would you choose for your patient?

Case Study: Pneumonia

Which pathway would you choose for your patient?

Webinar

The Impact of Rapid Diagnostics on Antimicrobial Stewardship